2004
DOI: 10.1002/ardp.200300837
|View full text |Cite
|
Sign up to set email alerts
|

Antiaggregating and Antithrombotic Activities of new 1, 2, 3‐Triazolecarboxamides

Abstract: Twenty five new triazolecarboxamides related to YC-1 were prepared and tested for their antiplatelet (in vitro) and antithrombotic (in vivo) activities. Five of them inhibited the aggregation of blood platelets (Born test, inducer collagen) with IC50 values between 90 and 130 microM. Nine compounds exhibited significant antithrombotic properties with an inhibition of thrombus formation between 11 and 7%. Only one compound (8c) showed both, in vitro and in vivo effects. In vitro, the most active compounds were … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
27
0
3

Year Published

2005
2005
2017
2017

Publication Types

Select...
8

Relationship

5
3

Authors

Journals

citations
Cited by 37 publications
(30 citation statements)
references
References 4 publications
0
27
0
3
Order By: Relevance
“…The derivatives of triazole exhibit a variety of activities such as antitumor, 4) antiinflammatory, 5) antimicrobial, 6,7) antifugal, 8) antithrombotic, 9) antiplatelet, 10) antiviral, 11) and anticonvulsant activities. [12][13][14] In our search for new compounds with anticonvulsant activity, 6-benzyloxy-3,4-dihydro-1H-quinoline-2-one was found although its activity is low.…”
mentioning
confidence: 99%
“…The derivatives of triazole exhibit a variety of activities such as antitumor, 4) antiinflammatory, 5) antimicrobial, 6,7) antifugal, 8) antithrombotic, 9) antiplatelet, 10) antiviral, 11) and anticonvulsant activities. [12][13][14] In our search for new compounds with anticonvulsant activity, 6-benzyloxy-3,4-dihydro-1H-quinoline-2-one was found although its activity is low.…”
mentioning
confidence: 99%
“…After stirring for 64 h at a temperature of 30 to 40°C the mixture was filtered off. The filtrate was concentrated in vacuo at a temperature of less [9] modified)…”
Section: N-[2-(1-methylpyrrolidin-2-yl)-ethyl]-5-(biphenyl-4-yl)-13mentioning
confidence: 99%
“…In the row of the type 6 compounds the lipophilic biphenyl rest R 1 which already had proven to be very suitable for antiplatelet activities [9,10] was held constant (6a؊g, 6j) and R 2 was varied. Especially substituents with a basic moiety (pK B~5 ) were chosen according to former experiences with ether heterocycles [9,10]. The exception is 6f with neutral R 2 (i.e.…”
Section: Introductionmentioning
confidence: 99%
“…They are generally used in medicinal chemistry [15][16], organic chemistry, materials chemistry [17] and other fields, but they are rarely used in liquid crystal. In the linear molecule, a negative dielectric anisotropy can be obtained by introducing substituent group, such as cyanogroup [18], nitro [19], fluorine [20] and chlorine [21] to the side of the molecule.…”
Section: Introductionmentioning
confidence: 99%